Photo of Dr Victoria Johnston

Dr Victoria Johnston

Telephone:

Email:

Location:

  • University College Hospital
  • Hospital for Tropical Diseases

GMC/GDC number:

4369743

Professional background

Dr Victoria Johnston graduated in medicine from Cambridge University (1996) and trained in the UK, Australia, Myanmar and South Africa.

  • MSc and PhD in clinical epidemiology
  • consultant in infectious diseases and tropical medicine at HTD since 2013
  • Associate Professor London School of Hygiene and Tropical Medicine
  • Research interests in all areas of tropical medicine and HIV

Specialties

Research interests

Clinical tropical medicine, HIV

Publications

  • Javelle E, Florescu SA, Asgeirsson H, et al. Increased risk of chikungunya infection in travellers to Thailand during ongoing outbreak in tourist areas: cases imported to Europe and the Middle East, early 2019. Euro Surveill. 2019;24(10):1900146. doi:10.2807/1560-7917.ES.2019.24.10.1900146
  • Fink D, Wani RS, Johnston V. Fever in the returning traveller. BMJ. 2018;360:j5773. Published 2018 Jan 25. doi:10.1136/bmj.j5773
  • Ellis J, Hearn P, Johnston V. Assessment of returning travellers with fever. Medicine (Abingdon). 2018;46(1):2-9. doi:10.1016/j.mpmed.2017.10.006
  • Post FA, Szubert AJ, Prendergast AJ, Johnston V et al. Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial. Clin Infect Dis. 2018;66(suppl_2):S132-S139. doi:10.1093/cid/cix1141
  • Stockdale AJ, Saunders MJ, Boyd MA, Bonnett L, Johnston V et al. Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse Transcriptase Inhibitor-Based Second-line Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-Saharan Africa: A Systematic Review and Meta-analysis. Clin Infect Dis. 2018;66(12):1846-1857. doi:10.1093/cid/cix1108
  • Johnston V, Cohen K, Wiesner L, et al. Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug concentrations prior to switch. J Infect Dis. 2014;209(5):711-720. doi:10.1093/infdis/jit411
  • Johnston V, Fielding K, Charalambous S, Churchyard G, Phillips A, Grant AD. Outcomes following virological failure and predictors of switching to second-line antiretroviral therapy in a South African treatment programme. JAIDS 2012; 61(3); 370-80
  • Johnston V, Fielding K, Charalambous S, Mampho M, Churchyard G, Phillips A, Grant AD. Second line antiretroviral therapy in a workplace and community based treatment programmes in South Africa: determinants of virological outcome. PLoS ONE 2012; 7(5):e36997
  • Kranzer K, Govindasamy D, Ford N, Johnston V, Lawn SD. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review. J Int AIDS Soc. 2012;15(2):17383. Published 2012 Nov 19. doi:10.7448/IAS.15.2.17383
  • Johnston V, Stockely JM, Dockrell D, Warrell D, Bailey R, Pasvol G, Klein J, Ustianowski A, Jones M, Beeching NJ, Brown M, Chapman AL,Sanderson F, Whitty CJ. Fever in returning travellers presenting in the United Kingdom: recommendation for investigation and initial management. J Infect 2009;59(1):1-18
  • Hoffmann CJ, Fielding KL, Johnston V, et al. Changing predictors of mortality over time from cART start: implications for care. J Acquir Immune Defic Syndr. 2011;58(3):269-276. doi:10.1097/QAI.0b013e31823219d1